Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rachael L. Gerlach"'
Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia
Autor:
Fernando Carvalho Neuenschwander, Ofra Barnett-Griness, Stefania Piconi, Yasmin Maor, Eduardo Sprinz, Nimer Assy, Oleg Khmelnitskiy, Nikita Lomakin, Boris Mikhailovich Goloshchekin, Ewelina Nahorecka, Adilson Joaquim Westheimer Calvacante, Anastasia Ivanova, Sergey Vladimirovich Zhuravel, Galina Yurevna Trufanova, Stefano Bonora, Amer Saffoury, Ami Mayo, Yury Shvarts, Giuliano Rizzardini, Rogerio Sobroza de Mello, Janaina Pilau, Alexey Klinov, Benjamin Valente-Acosta, Oleg Olegovich Burlaka, Natalia Bakhtina, Maskit Bar-Meir, Ivan Nikolaevich Shishimorov, Jose Oñate-Gutierrez, Cristian Ivan Garcia Rincon, Tatiana Ivanovna Martynenko, Ludhmila Abrahão Hajjar, Ana Carolina Nazare de Mendonca Procopio, Krzystof Simon, Walter Gabriel Chaves Santiago, Adam Fronczak, Conrado Roberto Hoffmann Filho, Osama Hussein, Vladimir Aleksandrovich Martynov, Guido Chichino, Piotr Blewaska, Jacek Wroblewski, Sergio Saul Irizar Santana, Andres Felipe Ocampo Agudelo, Adam Barczyk, Rachael L. Gerlach, Eppie Campbell, Aida Bibliowicz, Reza Fathi, Patricia Anderson, Gilead Raday, Michal Klein, Clara Fehrmann, Gina Eagle, Vered Katz Ben-Yair, Mark L. Levitt
RationaleThere are few treatment options for severe COVID-19 pneumonia. Opaganib is an oral treatment under investigation.ObjectiveEvaluate opaganib treatment in hospitalized patients with severe COVID-19 pneumonia.MethodsA randomized, placebo-contro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ac5a8655eb260c38557cc88d09eaf63c
https://doi.org/10.1101/2022.06.12.22276088
https://doi.org/10.1101/2022.06.12.22276088
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e78912 (2013)
Replication, cell tropism and the magnitude of the host's antiviral immune response each contribute to the resulting pathogenicity of influenza A viruses (IAV) in humans. In contrast to seasonal IAV in human cases, the 2009 H1N1 pandemic IAV (H1N1pdm
Externí odkaz:
https://doaj.org/article/025b6d61fd554e2585adcb951ccff597
Autor:
Jeremy V Camp, Yong-Kyu Chu, Dong-Hoon Chung, Ryan C McAllister, Robert S Adcock, Rachael L Gerlach, Timothy L Wiemken, Paula Peyrani, Julio A Ramirez, James T Summersgill, Colleen B Jonsson
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56602 (2013)
To capture the possible genotypic and phenotypic differences of the 2009 influenza A virus H1N1 pandemic (H1N1pdm) strains circulating in adult hospitalized patients, we isolated and sequenced nine H1N1pdm viruses from patients hospitalized during 20
Externí odkaz:
https://doaj.org/article/2f104bf352874193b1e1b7901c4dd9e2
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 11, p e78912 (2013)
PLoS ONE, Vol 8, Iss 11, p e78912 (2013)
Replication, cell tropism and the magnitude of the host's antiviral immune response each contribute to the resulting pathogenicity of influenza A viruses (IAV) in humans. In contrast to seasonal IAV in human cases, the 2009 H1N1 pandemic IAV (H1N1pdm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bf6bb3ac01fc0f70a285c06dd3d3539
http://europepmc.org/articles/PMC3828299
http://europepmc.org/articles/PMC3828299
Autor:
James T. Summersgill, Julio A. Ramirez, Colleen B. Jonsson, Jeremy V. Camp, Rachael L. Gerlach, Ryan C. McAllister, Yong Kyu Chu, Robert S. Adcock, Donghoon Chung, Paula Peyrani, Timothy L. Wiemken
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 2, p e56602 (2013)
PLoS ONE, Vol 8, Iss 2, p e56602 (2013)
To capture the possible genotypic and phenotypic differences of the 2009 influenza A virus H1N1 pandemic (H1N1pdm) strains circulating in adult hospitalized patients, we isolated and sequenced nine H1N1pdm viruses from patients hospitalized during 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb1aa03f60b6e91f39a7ff366fc85e94
https://doi.org/10.1371/journal.pone.0056602
https://doi.org/10.1371/journal.pone.0056602